alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
BE F O R E TH E U. S . D E P AR T M E NT O F T RAN S P O R T A T I O N WA SH IN G TO N, D.C.

) A pp li ca ti on of ) ) P R I V I L E G E S T Y L E, S .A. ) ) D o c k e t N o. O S T

- 201 0

- 0 148 f

or a P ar t 212 St a t e m e nt of A u t ho r iz a ti on ) (U

. S

. – EU op e n sk i e s c o d e sh ar i n g ) ) )

) J o i n t A pp li ca ti on of ) ) D E L T A A I R L I N E S
, I N C . )

a nd ) D o c k e t N o. O S T

- 201 1

- 0 160 A I R E U R O P A L I N EAS A E R EA S
, S .A.U. ) ) f

or St a t e m e n t s of A u t ho r iz a ti on ) pu r su a nt t o 14 C

. F

. R

. P a r t 212 ) )

NOTICE OF CESSATION OF AIR EUROPA/PRIVILEGE STYLE JFK

- MADRID WET

- LEASE/CODE

- SHARE SERVICES

Communications with respect to this document should be addressed to:

Aaron A. Goerlich Garofalo Goerlich Hainbach PC 1200 New Hampshire Ave NW Washington DC 20036

- 6802 AGoerlich@ggh

- airlaw.com 202 776

- 3974

Counsel for Air Europa Lineas Aereas, S.A.U.

July 3 , 2014BE F O R E TH E U. S . D E P AR T M E NT O F T RAN S P O R T A T I O N WA SH IN G TO N, D.C.

) A pp li ca ti on of ) ) P R I V I L E G E S T Y L E, S

. A

. ) ) D o c k e t N o. O S T

- 201 0

- 0 148 f

or a P ar t 212 St a t e m e nt of A u t ho r iz a ti on ) (U

. S

. – EU op e n sk i e s c o d e sh ar i n g ) ) )

) J oi n t A pp li ca ti on of ) ) D E L T A A I R L I N E S
, I N C

. )

a nd ) D o c k e t N o. O S T

- 201 1

- 0 160 A I R E U R O P A L I N EAS A E R EA S
, S .A.U. ) ) f

or S t a t e m e nts of A utho r i z a tion ) pu r su a nt t o 14 C

. F

. R

. P a r t 212 ) )

NOTICE OF CES S ATION OF A IR EUROPA/PRIVILEGE STYLE JFK

- MADRID WET

- LEASE/CODE

- SHARE SERVICES

Air Europa Lineas Aereas, S.A.U. hereby notifies the Department that Air Europa
and Privilege Style, S.A. have ceased the wet

- lease/code

- share services between New
York (JFK) and Madrid, Spain, authorized by the Notice of Action Taken issued May 6,

2014 in the above dockets

. This notification is given pursuant to condition (b) of the May

6 Notice.

T his notification does not affect the continuing code

- share services
involving Air Europa and Delta Air Lines, Inc. authorized by the Department’s
Notice dated September 21, 2011 in Docket DOT

- OST

- 2011

- 0160. Nor does it

affect the continuing intra

- Europe wet

- lease/code

- sha re services involving Air
Europa, Delta and Privilege Style authorized by the Department’s Notice datedJanuary 30, 2013, in the above dockets.

R e sp ec t f ul l y submitt e d,

Aaron A. Goerlich Garofalo Goerlich Hainbach PC

Counsel for Air Europa Lineas Aereas, S.A.U.

July 3 , 2014
# C_2014102EN.01004502.xml

| 7.4.2014 | EN | Official Journal of the European Union | C 102/45 |
| --- | --- | --- | --- |

7.4.2014

EN

Official Journal of the European Union

C 102/45

---

Action brought on 7 February 2014 — ZZ v EEAS

(Case F-11/14)

2014/C 102/67

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: S. Rodrigues and A. Tymen, lawyers)

Applicant:

Defendant: European External Action Service (EEAS)

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the applicant’s contract in so far as he is placed in grade AD5 and for compensation for the damage allegedly suffered.

Form of order sought

Form of order sought

| — | Annul the decision of 1 April 2013 in so far as it places the applicant in grade AD5; |
| --- | --- |

—

Annul the decision of 1 April 2013 in so far as it places the applicant in grade AD5;

| — | If necessary, annul the decision of 28 October 2013 rejecting the applicant’s claim; |
| --- | --- |

—

If necessary, annul the decision of 28 October 2013 rejecting the applicant’s claim;

| — | Order the regrading of the applicant’s post to a grade corresponding to the level of his responsibilities; |
| --- | --- |

—

Order the regrading of the applicant’s post to a grade corresponding to the level of his responsibilities;

| — | Order the defendant to bear all the consequences, in particular financial, of that regrading, retroactively since his entry into the service; |
| --- | --- |

—

Order the defendant to bear all the consequences, in particular financial, of that regrading, retroactively since his entry into the service;

| — | Compensate the applicant for the non-pecuniary damage suffered, assessed ex aequo et bono at EUR 5 000; |
| --- | --- |

—

Compensate the applicant for the non-pecuniary damage suffered, assessed ex aequo et bono at EUR 5 000;

ex aequo et bono

| — | Order the EEAS to pay all the costs. |
| --- | --- |

—

Order the EEAS to pay all the costs.

---
U.S. Department of the Interior

U.S. Geological Survey

General Information Product 171

ver. 1.1, February 2019

Earth Resources Observation and Science (EROS) Center

U.S. Geological Survey (USGS) Popular Websites

EROS Center 

usgs.gov/eros

Data Visualization and Access Products

EarthExplorer 

earthexplorer.usgs.gov

EarthNow! Landsat Viewer

earthnow.usgs.gov

Global Visualization Viewer (GloVis)

glovis.usgs.gov

Hazards Data Distribution System (HDDS) 

Explorer

hddsexplorer.usgs.gov

LandsatLook Viewer

landsatlook.usgs.gov

Land Processes Distributed Active Archive 

Center (LP DAAC)

lpdaac.usgs.gov

What’s Happening at EROS?

Landsat Missions

usgs.gov/land-resources/nli/landsat

EROS CalVal Center of Excellence (ECCOE)

usgs.gov/land-resources/eros/calval

EROS Publications

usgs.gov/centers/eros/publications

EROS History Project

usgs.gov/centers/eros/about/eros-history

EROS Multimedia

usgs.gov/centers/eros/multimedia

Popular USGS Sites

USGS

usgs.gov

USGS Employment

usgs.gov/ohr; usajobs.gov

USGS Frequently Asked Questions (FAQs)

usgs.gov/faq

USGS Store

store.usgs.gov

USGS Science Education

Resources for K–12 and undergraduate 

teachers

usgs.gov/education

For more information, please contact:

U.S. Geological Survey

Earth Resources Observation and Science (EROS) Center

47914 252nd Street

Sioux Falls, SD 57198–0001

Toll free: 800–252–4547

Telephone: 605–594–6151

E-mail: custserv@usgs.gov

ISSN 2332-354X (online)

https://doi.org/10.3133/gip171

Supersedes USGS General Information Product 84
#### § 573.870 Poly(2-vinylpyridine-co-styrene).

The food additive poly(2-vinylpyridine-co-styrene) may be safely used as nutrient protectant in feed for beef cattle and dairy cattle and replacement dairy heifers when used in accordance with the following conditions:

(a) The additive meets the following specifications:

| Component/property | Limitation |
| --- | --- |
| Inherent viscosity | 1.0-1.6 deciliter per gram.1 |
| Styrene moiety | 40 percent maximum. |
| 2-Vinylpyridine moiety. | 90 percent maximum. |
| Residual styrene | 200 parts per billion maximum. |
| Residual 2-vinylstyrene | 200 parts per billion maximum. |
| Heavy metals such as lead | 10 parts per million maximum. |
| Arsenic | 3 parts per million maximum. |
| | |
| --- | --- |
| 1 Inherent viscosity of a 0.25 percent (weight/volume) solution in dimethylformamide. | |

(b) The additive is used in the manufacture of rumen-stable, abomasum-dispersible nutrient(s) for beef cattle and dairy cattle and replacement dairy heifers such that the maximum use of the additive from all sources does not exceed 5.1 grams per head per day. The additive may be used to protect the following nutrients:

(1) *Methionine.* The resulting product must contain a maximum of 10 percent poly(2-vinylpyridine-co-styrene) by weight and a minimum of 55 percent methionine by weight. The coated methionine must be established through in vitro tests to be at least 90 percent rumen-stable, of which at least 90 percent is subsequently dispersible under abomasal conditions.

(2) *Methionine and lysine.* The resulting product must contain a maximum of 10 percent poly(2-vinylpyridine-co-styrene) by weight and a minimum of a combined total of 55 percent methionine and lysine by weight. The coated methionine and lysine must be established through in vitro tests to be at least 90 percent rumen-stable, of which at least 90 percent is subsequently dispersible under abomasal conditions.

(c) *Label and labeling.* To ensure safe use of the additive, the label and labeling of the additive and of any feed additive supplement, feed additive concentrate, feed additive premix, or liquid feed supplement prepared therefrom, shall bear, in addition to the other information required by the Federal Food, Drug, and Cosmetic Act, the following:

(1) The name of the additive.

(2) A statement of the concentration of poly(2-vinylpyridine-co-styrene) in any product or mixture.

(3) Adequate directions for the use of the rumen-stable, abomasum-dispersible nutrient(s) products.

(4) The following statement: “Warning: Maximum use of poly(2-vinylpyridine-co-styrene) from all sources is not to exceed 5.1 grams per head per day.”

[[57 FR 7875](https://www.federalregister.gov/citation/57-FR-7875), Mar. 5, 1992, as amended at [57 FR 24187](https://www.federalregister.gov/citation/57-FR-24187), June 8, 1992; [61 FR 11547](https://www.federalregister.gov/citation/61-FR-11547), Mar. 21, 1996; [70 FR 13100](https://www.federalregister.gov/citation/70-FR-13100), Mar. 18, 2005]
#### § 516.117 Submission of correspondence under this subpart.

Unless directed otherwise by FDA, all correspondence relating to any aspect of the new animal drug indexing process described in this subpart must be addressed to the Director, OMUMS. The initial correspondence for a particular index listing should include the name and address of the authorized contact person. Notifications of changes in such person or changes of address of such person should be provided in a timely manner.
**Exhibit 23.1**

 

**INDEPENDENT AUDITORS’ CONSENT**

 

We consent to the incorporation by reference in Registration Statement Nos. 333-111978, 333-108617, 333-81208, 333-71954,333-70976, 333-60132, 333-43038, 333-40322 and 333-35876 on Form S-3 and Nos. 333-108619, 333-70982, 333-38964 and 333-35874 on Form S-8 of GlycoGenesys, Inc. of our report dated March 29, 2004 (which report expresses an unqualified opinion andincludes an explanatory paragraph referring to the Company’s ability to continue as a going concern), relating to the consolidated financial statements of GlycoGenesys, Inc. as of and for the years ended December 31, 2003 and 2002 appearing inthis Annual Report on Form 10-K of GlycoGenesys, Inc. for the year ended December 31, 2003. 

 

/s/    DELOITTE & TOUCHE LLP 

 

Boston, Massachusetts 

March 29, 2004
Exhibit 10.48


 


Employee Stock Ownership Plan of







Dime Community Bancshares, Inc. and Certain Affiliates 


 


Amendment Number Six


 


Amendment Number Six to the Employee Stock Ownership Plan of Dime Community Bancshares, Inc. and Certain Affiliates (the "ESOP).


 


The ESOP is hereby amended by adding the following new Section 6.6:


 


"Section  6.6.   Share Acquisition Loan Repayment.


 


The Committee may at any time direct the Trustee to (i) sell Shares held as collateral with respect to any Share Acquisition Loan and repay such loan with the sale proceeds or (ii) transfer to the lender a number of Shares held as collateral with respect to such loan with a Fair Market Value sufficient to repay the loan. After repayment of the Share Acquisition Loan, any remaining Shares which had been unallocated (or the proceeds thereof, if applicable) shall be allocated among the accounts of all Participants who were employed by an Employer on the loan repayment date (each, an "affected Participant"). Such allocation of Shares or proceeds shall be credited as of the loan repayment date to the Accounts of each affected Participant in proportion to the balances credited to such Accounts immediately prior to such allocation, taking into account the effect of allocations attributable to any regularly scheduled loan payments made prior to the loan repayment. If any amount cannot be allocated to an affected Participant in the year of such loan repayment as a result of the limitations of section 415 of the Code, such amounts will be allocated in subsequent years to those persons who were affected Participants and who continue to be Participants in the Plan until finally distributed to affected Participants."







This Amendment to the ESOP is effective as of_______________, 2016 and was executed on _______________, 2016.


 



	
 

	
DIME COMMUNITY BANCSHARES, INC.
Editorial Note on Part 60
Editorial Note: Nomenclature changes to part 60 appear at 68 FR 24879, May 9, 2003, and at 88 FR 45065, July 14, 2023.

§ 60.20 FDA action on regulatory review period determinations. ( a ) FDA will consult its records and experts to verify the dates contained in the application and to determine the length of the product's regulatory review period under § 60.22. The application shall contain information relevant to the determination of the regulatory review period as stated in the “Guidelines for Extension of Patent Term Under 35 U.S.C. 156” published on October 9, 1984, in PTO's *Official Gazette* and as required by 37 CFR chapter I.
( b ) After determining the length of the regulatory review period, FDA will notify PTO in writing of its determination, send a copy of this determination to the applicant, and file a copy of the determination in the docket established for the application in FDA's Dockets Management Staff (HFA-305), 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
( c ) FDA will also publish the regulatory review period determination in the Federal Register. The notice will include the following: ( 1 ) The name of the applicant;
( 2 ) The trade name and generic name (if applicable) of the product;
( 3 ) The number of the patent for which an extension of the term is sought;
( 4 ) The approved indications or uses for the product;
( 5 ) An explanation of any discrepancies between the dates in the application and FDA records;
( 6 ) Where appropriate, an explanation that FDA has no record in which to review the date(s) contained in the application; and
( 7 ) The regulatory review period determination, including a statement of the length of the testing and approval phases and the dates used in calculating each phase.
[53 FR 7305, Mar. 7, 1988, as amended at 59 FR 14364, Mar. 28, 1994]
<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 15, 1999.

                              THE LOEWEN GROUP INC.
             (Exact name of registrant as specified in its charter)

<TABLE>
<S>                                    <C>                             <C>
    British Columbia, Canada                    0-18429                           98-0121376
-------------------------------        ------------------------        ---------------------------------
(State or other jurisdiction of        (Commission File Number)        (IRS Employer Identification No.)
         incorporation)
</TABLE>

4126 Norland Avenue, Burnaby, British Columbia           V5G 3S8
----------------------------------------------          ----------
  (Address of principal executive offices)              (zip code)

Registrant's telephone number, including area code      604-299-9321


                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)



                                                      Exhibit Index is on page 3
                                                                     Page 1 of 5

<PAGE>   2

ITEM 5.  OTHER EVENTS.

Pursuant to Form 8-K, General Instructions F, registrant hereby incorporates by
reference the press release attached hereto as Exhibit 99.

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

<TABLE>
<CAPTION>
         Exhibit No.     Description
         -----------     -----------
         <S>             <C>
         Exhibit 99      The Loewen Group Inc. Press Release dated December 15,
                         1999.
</TABLE>


                                   SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: December 15, 1999.

                                         THE LOEWEN GROUP INC.

                                         By: /s/ BRADLEY D. STAM
                                             -----------------------------------
                                         Name:  Bradley D. Stam
                                         Title: Senior Vice President, Law


<PAGE>   3

                                  EXHIBIT INDEX

<TABLE>
<CAPTION>
                                                                    Sequential
Number         Exhibit                                              Page Number
------         -------                                              -----------
<S>            <C>                                                  <C>
99             The Loewen Group Inc.
               Press Release dated December 15, 1999                    4
</TABLE>
PUBLIC LAW 115–293—DEC. 6, 2018 132 STAT. 4377 

LEGISLATIVE HISTORY—H.R. 5737: 

CONGRESSIONAL RECORD, Vol. 164 (2018): 

Sept. 13, considered and passed House. 

Nov. 15, considered and passed Senate. 

Æ 

Public Law 115–293 

115th Congress 

An Act 

To designate the facility of the United States Postal Service located at 108 West 

D Street in Alpha, Illinois, as the ‘‘Captain Joshua E. Steele Post Office’’. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. CAPTAIN JOSHUA E. STEELE POST OFFICE. 

(a) DESIGNATION.—The facility of the United States Postal 

Service located at 108 West D Street in Alpha, Illinois, shall be 

known and designated as the ‘‘Captain Joshua E. Steele Post Office’’. 

(b) REFERENCES.—Any reference in a law, map, regulation, 

document, paper, or other record of the United States to the facility 

referred to in subsection (a) shall be deemed to be a reference 

to the ‘‘Captain Joshua E. Steele Post Office’’. 

Approved December 6, 2018. 

Dec. 6, 2018 

[H.R. 5737] 


ralbany on LAP520R082 with PUB LAWS PDF
§ 582.5455 Manganese glycerophosphate. ( a ) *Product.* Manganese glycerophosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     Financial Data Schedule for Preferred Voice, Inc.
</LEGEND>
<CIK>                         0000946822
<NAME>                        Preferred Voice, Inc.
<MULTIPLIER>                  1
<CURRENCY>                    U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>               MAR-31-2000
<PERIOD-START>                  APR-01-1999
<PERIOD-END>                    MAR-31-2000
<EXCHANGE-RATE>                 1
<CASH>                          1,373,291
<SECURITIES>                    0
<RECEIVABLES>                   3,924
<ALLOWANCES>                    0
<INVENTORY>                     84,724
<CURRENT-ASSETS>                1,461,939
<PP&E>                          763,012
<DEPRECIATION>                  253,143
<TOTAL-ASSETS>                  2,845,215
<CURRENT-LIABILITIES>           811,773
<BONDS>                         0
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        13,277
<OTHER-SE>                      2,022,033
<TOTAL-LIABILITY-AND-EQUITY>    2,845,215
<SALES>                         885,134
<TOTAL-REVENUES>                885,134
<CGS>                           215,293
<TOTAL-COSTS>                   215,293
<OTHER-EXPENSES>                0
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              28,556
<INCOME-PRETAX>                 (1,053,042)
<INCOME-TAX>                    (1,053,042)
<INCOME-CONTINUING>             (1,053,042)
<DISCONTINUED>                  0
<EXTRAORDINARY>                 59,976
<CHANGES>                       0
<NET-INCOME>                    (993,066)
<EPS-BASIC>                     (0.10)
<EPS-DILUTED>                   (0.09)



</TABLE>
Exhibit 99.2

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Mackie Designs Inc. (the "Company") on Form 10-K for the period ended December 31, 2002
as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William A. Garrard, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §
1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



|Dated: April 15, 2003 |  | By: |  | /s/WILLIAM A. GARRARDVice President, Finance and Chief Financial Officer (Principal Financial and
Accounting Officer)
|--------------------- |  | --- |  | ---------------------------------------------------------------------------------------------------------------------

---

QuickLinks
# C_2014235EN.01003401.xml

| 21.7.2014 | EN | Official Journal of the European Union | C 235/34 |
| --- | --- | --- | --- |

21.7.2014

EN

Official Journal of the European Union

C 235/34

---

Action brought on 26 May 2014 — ZZ v EMCDDA

(Case F-22/14)

2014/C 235/45

Language of the case: English

Parties

Parties

Applicant: ZZ (represented by: L. Levi and M. Vandenbussche, lawyers)

Applicant:

Defendant: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

The annulment of the decision rejecting the applicant’s request that she be found to have suffered psychological harassment at the hands of her immediate superior and, second, the decision not to renew her contract, and of two other decisions rejecting her complaints against her superiors. The applicant accordingly also requests that a new investigation be carried out and seeks compensation for the material and non-material harm allegedly caused.

Form of order sought

Form of order sought

| — | Annul the decision of the applicant’s EMCDDA Director of 11 September 2012 rejecting the applicant’s request; |
| --- | --- |

—

Annul the decision of the applicant’s EMCDDA Director of 11 September 2012 rejecting the applicant’s request;

| — | annul the decision of 14 September 2012 not to renew the applicant’s contract; |
| --- | --- |

—

annul the decision of 14 September 2012 not to renew the applicant’s contract;

| — | annul the decision of the Chairman of the Management Board of the EMCDDA of 13 May 2013 and that of the applicant’s EMCDDA Director of 25 June 2013 which rejected the applicant’s allegations in her complaint of 10 December 2013; |
| --- | --- |

—

annul the decision of the Chairman of the Management Board of the EMCDDA of 13 May 2013 and that of the applicant’s EMCDDA Director of 25 June 2013 which rejected the applicant’s allegations in her complaint of 10 December 2013;

| — | order a new regular, unbiased and impartial investigation; |
| --- | --- |

—

order a new regular, unbiased and impartial investigation;

| — | grant compensation for the material prejudice suffered by the applicant, estimated at EUR 4 30  202; |
| --- | --- |

—

grant compensation for the material prejudice suffered by the applicant, estimated at EUR 4 30  202;

| — | grant compensation for the moral prejudice suffered by the applicant, estimated at EUR 1 20  000; |
| --- | --- |

—

grant compensation for the moral prejudice suffered by the applicant, estimated at EUR 1 20  000;

| — | order the defendant to pay the costs. |
| --- | --- |

—

order the defendant to pay the costs.

---